Na-Young Shin1, Injoong Kim2, Yunjin Bak1, Phil Hyu Lee3, Seung-Koo Lee4, and Soo Mee Lim5
1Department of Radiology, Ewha Womans University School of Medicine, Seoul, Korea, Republic of, 2Department of Radiology, Veterans Health Service Medical Center, 3Department of Neurology, Yonsei University College of Medicine, 4Department of Radiology, Yonsei University College of Medicine, 5Department of Radiology, Ewha Womans University School of Medicine
Synopsis
Degenerative change in the nucleus basalis of
Meynert, a group of cholinergic neurons in the substantia innominata (SI) of
the basal forebrain, begins in the early stages of Parkinson disease (PD)
and is known to be significantly correlated with cognitive performance. We
found decreased resting state functional connectivity (rsFC) in bilateral
frontal areas using bilateral SI mask as a seed and significant correlation
between decreased rsFC and shorter disease duration before mild cognitive
impairment was diagnosed in patients with Parkinson’s disease. Therefore, our
results support that cholinergic deficit plays an important role in the
acceleration of cognitive decline and conversion to PD dementia.
INTRODUCTION
Degenerative change in the nucleus basalis of
Meynert (NbM), a group of cholinergic neurons in the substantia innominata (SI)
of the basal forebrain, begins in the early stages of Parkinson disease (PD)
and is known to be significantly correlated with cognitive performance.1
We aimed to evaluate the different patterns of functional and structural
changes in the SI of PD patients with mild cognitive impairment (PD-MCI)
according to the duration of parkinsonism observed before mild cognitive
impairment (MCI) was diagnosed using resting state functional magnetic
resonance imaging (rsfMRI) and region of interest (ROI)-based volumetric
analyses.
METHODS
Fifty-four patients with PD-MCI were
classified into either the shorter (PD-MCI-SD, <1 year, n = 27) or longer (PD-MCI-LD,
≥1 year, n = 27) duration group according to duration of parkinsonism before MCI
was diagnosed. Thirty-six age- and sex-matched drug-naïve PD patients
with intact cognition (PD-IC) were included for comparison. Seed-based resting
state functional connectivity (rsFC) analysis using the bilateral SI mask as a
seed and ROI-based volumetric analysis were performed. Age, sex, years of
education, age at onset of parkinsonism, and levodopa-equivalent dose were
included as covariates. RESULTS
Compared to the PD-IC group, the collapsed
PD-MCI group (PD-MCI-SD and PD-MCI-LD; n=54) showed decreased rsFC in the left
frontal area, while increased rsFC was observed in the bilateral parietal areas
(Figure 1).
Compared
to the PD-IC group, the PD-MCI-SD group exhibited decreased rsFC in the bilateral
frontal areas, while increased rsFC was observed in the bilateral parietal
areas. The PD-MCI-LD group exhibited decreased rsFC in the bilateral primary
motor sensory areas and cuneus, and increased rsFC in the right temporal area
compared to the PD-IC group. In a direct comparison between the
PD-MCI-SD and PD-MCI-LD groups, the PD-MCI-SD group showed decreased rsFC in both
the frontal and right parietal areas. On the other hand, the PD-MCI-LD group
showed decreased functional connectivity in the bilateral primary motor sensory
areas and both occipital areas (Figure 2). Moreover, Spearman’s correlation
analysis showed significant associations between shorter disease duration with
decreased rsFC in both frontal areas (rho= 0.212, P =
0.047; Figure 3).
The mean SI
volumes for the three groups were as follows: PD-IC, 0.999±0.157ml; PD-MCI-LD, 0.981±0.174ml;
and PD-MCI-SD, 0.957±0.186ml, respectively. The PD-MCI-SD group showed the
lowest value; however, there were no significant differences across the groups
statistically (P=0.650). DISCUSSION
Decreased rsFC in the left frontal area and increased rsFC in the bilateral
parietal areas was observed in collapsed PD-MCI compared to PD-IC when the bilateral
SI mask was used as a seed, suggesting these areas are relevant to cognitive
dysfunction in PD patients. The PD-MCI-SD group showed rsFC alteration in
broader cognitive dysfunction related areas compared to PD-IC as well as the PD-MCI-LD
groups without significant structural changes in SI. Among these areas, the
decreased rsFC between the bilateral SI seed and both frontal areas had
significant correlation with shorter disease duration in PD patients,
supporting previous results2 which suggested that cholinergic
deficit played an important role in the acceleration of cognitive decline and
conversion to PD dementia.CONCLUSION
Our results suggest that decreased rsFC
between the SI and bilateral frontal areas might be a sensitive and noninvasive
neuroimaging
biomarker that reflects cortical cholinergic denervation in the NbM which also predicts
rapid cognitive decline. This altered rsFC can become a future therapeutic
target for novel treatment modalities (e.g., transcranial direct current
stimulation or transcranial magnetic stimulation). Furthermore, this could be used
to identify suitable PD patients for targeted cholinergic drug treatment and to
monitor treatment effect. To enable these clinical applications, a subject-level
diagnostic and prognostic model should be first established.Acknowledgements
No acknowledgement found.References
1.
Braak, H., et al., Staging of brain pathology related to sporadic Parkinson's disease.
Neurobiol Aging, 2003. 24(2): p.
197-211.
2.
Kehagia, A.A., R.A. Barker, and T.W. Robbins, Cognitive impairment in Parkinson's disease:
the dual syndrome hypothesis. Neurodegener Dis, 2013. 11(2): p. 79-92.